Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer (original) (raw)

• Akbar AN, Vukmanovic-Stejic M, Taams LS et al (2007) The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat Rev Immunol 7:231–237
  Article CAS PubMed Google Scholar
• Bates GJ, Fox SB, Han C et al (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24:5373–5380
  Article PubMed Google Scholar
• Berendt MJ, North RJ (1980) T-cell-mediated suppression of anti-tumor immunity An explanation for progressive growth of an immunogenic tumor. J Exp Med 151:69–80
  Article CAS PubMed Google Scholar
• Boon T, Cerottini JC, Van den Eynde B et al (1994) Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12:337–365
  Article CAS PubMed Google Scholar
• Chen W, Jin W, Hardegen N et al (2003) Conversion of peripheral CD4+ CD25− naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875–1886
  Article CAS PubMed Google Scholar
• Cohen AM, Tremiterra S, Candela F et al (1991) Prognosis of node-positive colon cancer. Cancer 67:1859–1861
  Article CAS PubMed Google Scholar
• Curiel TJ, Coukos G, Zou L et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949
  Article CAS PubMed Google Scholar
• Drake CG, Jaffee E, Pardoll DM (2006) Mechanisms of immune evasion by tumors. Adv Immunol 90:51–81
  Article CAS PubMed Google Scholar
• Dunn GP, Bruce AT, Ikeda H et al (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3:991–998
  Article CAS PubMed Google Scholar
• Fantini MC, Becker C, Monteleone G et al (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25− T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172:5149–5153
  CAS PubMed Google Scholar
• Fu J, Xu D, Liu Z et al (2007) Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132:2328–2339
  Article PubMed Google Scholar
• Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960–1964
  Google Scholar
• Gao Q, Qiu SJ, Fan J et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586–2593
  Article PubMed Google Scholar
• Grabenbauer GG, Lahmer G, Distel L et al (2006) Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. Clin Cancer Res 12:3355–3360
  Article CAS PubMed Google Scholar
• Hashimoto K, Nio Y, Sumi S et al (2001) Correlation between TGF-b1 and p21 (WAF1/CIP1) expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. Pancreas 22:341–347
  Article CAS PubMed Google Scholar
• Hiraoka N, Onozato K, Kosuge T et al (2006) Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12:5423–5434
  Article CAS PubMed Google Scholar
• Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–1061
  Article CAS PubMed Google Scholar
• Jass JR (1986) Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol 39:585–589
  Article CAS PubMed Google Scholar
• Ling KL, Pratap SE, Bates GJ et al (2007) Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun 7:7
  PubMed Google Scholar
• Liyanage UK, Moore TT, Joo HG et al (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169:2756–2761
  CAS PubMed Google Scholar
• Loddenkemper C, Schernus M, Noutsias M et al (2006) In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer. J Transl Med 4:52
  Article PubMed Google Scholar
• Maloy KJ, Powrie F (2001) Regulatory T cells in the control of immune pathology. Nat Immunol 2:816–822
  Article CAS PubMed Google Scholar
• Marie JC, Letterio JJ, Gavin M et al (2005) TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+ CD25+ regulatory T cells. J Exp Med 201:1061–1067
  Article CAS PubMed Google Scholar
• Naito Y, Saito K, Shiiba K et al (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491–3494
  CAS PubMed Google Scholar
• Nomura T, Sakaguchi S (2005) Naturally arising CD25+ CD4+ regulatory T cells in tumor immunity. Curr Top Microbiol Immunol 293:287–302
  Article CAS PubMed Google Scholar
• Peng Y, Laouar Y, Li MO et al (2004) TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+ CD25+ regulatory T cells responsible for protection against diabetes. P Natl Acad Sci USA 101:4572–4577
  Article CAS Google Scholar
• Ropponen KM, Eskelinen MJ, Lipponen PK et al (1997) Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182:318–324
  Article CAS PubMed Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M et al (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164
  CAS PubMed Google Scholar
• Sakaguchi S (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455–458
  Article CAS PubMed Google Scholar
• Sasada T, Kimura M, Yoshida Y et al (2003) CD4+ CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98:1089–1099
  Article PubMed Google Scholar
• Sato E, Olson SH, Ahn J et al (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. P Natl Acad Sci USA 102:18538–18543
  Article CAS Google Scholar
• Shevach EM (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2:389–400
  CAS PubMed Google Scholar
• Sundrud MS, Rao A (2007) New twists of T cell fate: control of T cell activation and tolerance by TGF-beta and NFAT. Curr Opin Immunol 19:287–293
  Article CAS PubMed Google Scholar
• Vukmanovic-Stejic M, Zhang Y, Cook JE et al (2006) Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 116:2423–2433
  Article CAS PubMed Google Scholar
• Wolf AM, Wolf D, Steurer M et al (2003) Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 9:606–612
  PubMed Google Scholar
• Wolf D, Wolf AM, Rumpold H et al (2005) The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 11:8326–8331
  Article CAS PubMed Google Scholar
• Woo EY, Yeh H, Chu CS et al (2002) Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 168:4272–4276
  CAS PubMed Google Scholar
• Zhang L, Conejo-Garcia JR, Katsaros D et al (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203–213
  Article CAS PubMed Google Scholar